| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.033 | 0.6 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.035 | 0.7 |